Related Experiment Videos
Pelvic exenteration: a review of the Gateshead experience 1974-1992
G Robertson1, A Lopes, G Beynon
1Department of Gynaecological Oncology, Queen Elizabeth Hospital, Gateshead, Tyne, UK.
Objective:
To examine morbidity and survival among women treated by pelvic exenteration for gynaecological malignancy.
Design:
Retrospective review by analysis of case records.
Setting:
Department of Gynaecological Oncology, Queen Elizabeth Hospital, Gateshead, UK.
Subjects:
Eighty-three consecutive patients referred from within the UK from 1974 to 1992 for initial treatment of advanced gynaecological malignancy or management of recurrent disease following unsuccessful initial therapy.
Results:
Overall five year actuarial survival was 41%, falling to 36% at 10 years. Serious morbidity was low, and there were only three peri-operative deaths.
Conclusions:
For patients with limited options for treatment of advanced primary or recurrent cancer, exenteration offers a reasonable prospect of survival with good quality of life.